Skip to main content
G

GenMont Biotech Incorporation — Investor Relations & Filings

Ticker · 3164 TW Manufacturing
Filings indexed 1,611 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont Biotech Incorporation

https://www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_3164_20260608FE2.pdf
Regulatory Filings
2026-05-04 English
115年年報及股東會資料 — 2026_3164_20260608F02.pdf
Regulatory Filings
2026-05-04 Chinese
115年年報及股東會資料 — 2026_3164_20260608F13.pdf
Regulatory Filings
2026-05-04 Chinese
115年年報及股東會資料 — 2026_3164_20260608F01.pdf
Regulatory Filings
2026-05-04 Chinese
公告115年第一季財務報告董事會召開日期為115年5月6日
Report Publication Announcement Classification · 1% confidence The document is a brief public notice by a listed company to announce the convocation date of the board meeting that will approve the Q1 financial report. There is no actual financial report content; it only states the notice date, meeting date, and intended agenda item (Q1 report). This fits “Report Publication Announcement (RPA)”—a short announcement regarding the timing or scheduling of a company report—rather than the report itself.
2026-04-28 Chinese
114年第4季財務報告書 — 202504_3164_AIC.pdf
Audit Report / Information Classification · 1% confidence The document is titled “Parent Company Only Financial Statements for the Years Ended December 31, 2025 and 2024 and Independent Auditors’ Report,” contains the independent auditors’ opinion, audit scope, key audit matters, and the audited balance sheets, income statements, cash flow statements, and notes. It is a standalone audited financial report rather than a full corporate annual report with MD&A or a brief earnings release. Therefore, it fits the definition of a standalone Audit Report / Information (AR).
2026-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.